ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $146,679,000 | -16.0% | 1,385,465 | -32.3% | 0.03% | -15.0% |
| Q2 2021 | $174,637,000 | -33.2% | 2,045,653 | -10.2% | 0.04% | -39.4% |
| Q1 2021 | $261,357,000 | -35.7% | 2,277,026 | -21.5% | 0.07% | -40.5% |
| Q4 2020 | $406,256,000 | +39.1% | 2,901,828 | -19.1% | 0.11% | +23.3% |
| Q3 2020 | $292,039,000 | +18.0% | 3,585,500 | +4.1% | 0.09% | +11.1% |
| Q2 2020 | $247,415,000 | +55.9% | 3,443,010 | -3.5% | 0.08% | +24.6% |
| Q1 2020 | $158,736,000 | -58.4% | 3,567,911 | -10.8% | 0.06% | -50.0% |
| Q4 2019 | $381,565,000 | +42.4% | 4,001,310 | +17.4% | 0.13% | +27.5% |
| Q3 2019 | $268,034,000 | +285.9% | 3,408,807 | +112.6% | 0.10% | +264.3% |
| Q2 2019 | $69,460,000 | +24.5% | 1,603,056 | +16.4% | 0.03% | +16.7% |
| Q1 2019 | $55,800,000 | +10.8% | 1,377,781 | +43.0% | 0.02% | -4.0% |
| Q4 2018 | $50,354,000 | +34.5% | 963,347 | +15.7% | 0.02% | +47.1% |
| Q3 2018 | $37,447,000 | – | 832,335 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |